Bizarre Patents
A haircutting appliance comprises an enclosed housing having a hollow handle connecting the housing to a vacuum source to carry away cut hairs from a subject's head.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7276538 | Composition and a method for treating hair loss The use of the polyamine known as spermidine, i.e., N-(3-aminopropyl) tetraminethylenediamine, as an active principle in the preparation of a composition for pharmaceutical or dietetic use in man for combating hair loss is disclosed. ... | 10/02/2007 |
| 6974838 | Methods of treating or preventing pain using sibutramine metabolites Methods of making and using racemic and optically pure metabolites of sibutramine, and pharmaceutically acceptable salts, solvates, and clathrates thereof, are disclosed. Pharmaceutical compositions and dosage forms are also disclosed which comprise a dopamine reupt... | 12/13/2005 |
| 6469040 | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia This invention relates to the use of cyclooxygenase-2 inhibitors or derivatives thereof in preventing and treating neoplasia. In particular, the invention describes the method of preventing and treating epithelial cell neoplasia in a subject, said method ... | 10/22/2002 |
| 6358944 | Methods and compositions for treating generalized anxiety disorder The present invention relates to methods and compositions comprising a very low dose of cyclobenzaprine or metabolite thereof for preventing and treating Generalized Anxiety Disorder. The present invention further relates to methods and compositions for t... | 03/19/2002 |
| 6169105 | Potentiation of drug response The power of citalopram, fluvoxamine and paroxetine to increase the availability of sarotonin, norepinephrine and dopamine, particularly serotonin, is augmented by administration in combination with a drug which is a serotonin 1A receptor antagonist.... | 01/02/2001 |
| 6028073 | N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics N-substitued 3-azabicyclo[3.2.0]heptane derivatives of formula (I) ##STR1## in which R1, R2, A, X, Y and Z have the meanings given in the description, their method of preparation and their use as pharmacological agents.... | 02/22/2000 |
| 6001842 | Compositions and methods for use in ischemia-reperfusion and endotoxin-related tissue injury Methods of preventing or treating ischemia-reperfusion injury in an organ by administration of a composition containing a selective A1 adenosine receptor antagonist and/or a P2X purinoceptor antagonist are provided. Methods of preven... | 12/14/1999 |
| 5965564 | Enantiomerically pure hydroxylated xanthine compounds There is disclosed compounds and pharmaceutical compositions that are a resolved R or S (preferably R) enantiomer of an ω-1 alcohol of a straight chain alkyl (C5-8) substituted at the 1-position of 3,7-disubstituted xanthine. The inventive com... | 10/12/1999 |
| 5817666 | Dermatological preparation and method for treating actinic keratoses using 5-FU A composition for the treatment of actinic keratoses includes 5-fluorouracil and an alpha hydroxy carboxylic acid. The composition may further include ancillary ingredients. A therapeutic method involving the composition and a kit for carrying out the tre... | 10/06/1998 |
| 5770607 | Aqueous liquid composition for external use This invention relates to an aqueous liquid composition for external use which contains a tricyclo compound of the chemical formula (I) presented here-under or a pharmaceutically acceptable salt thereof. More particularly, the invention relates to an aque... | 06/23/1998 |
| 5668155 | Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders Disclosed are methods for improving various aberrant metabolic indices in mammals including humans by administration of muscarinic (particularly M1) receptor antagonists alone or in combination with prolactin inhibiting compounds. Preferably the administr... | 09/16/1997 |
| 5648357 | Enatiomerically pure hydroxylated xanthine compounds There is disclosed compounds and pharmaceutical compositions that are a resolved R or S (preferably R) enantiomer of an ω-1 alcohol of a straight chain alkyl (C5-8) substituted at the 1-position of 3,7-disubstituted xanthine. The inventive com... | 07/15/1997 |
| 5635512 | Method for modifying or resetting the prolactin rhythm of an insulin insensitive or diabetic animal or human A process for the long term modification and regulation of linid and glucose metabolism--generally to reduce obesity, insulin resistance, and hyperinsulinemia or hyperglycemia, or both (these being the hallmarks of noninsulin dependent, or Type II diabete... | 06/03/1997 |
| 5234929 | Method of treating motion sickness with anticonvulsants and antitussive agents A method of treating or preventing motion sickness is disclosed which comprises administering an anti-motion sickness effective amount of an anticonvulsant compound such as phenytoin, ethotoin, primidone, ethosuximide or carbamazepine, in combination with... | 08/10/1993 |
| 5141943 | 5-benzyl barbiturate derivatives 5-benzyl barbiturate compounds for use as water-soluble uridine phosphorylase inhibitors are disclosed. These compounds are useful for reducing the toxicity and anemia induced by antiviral drugs such as AZT, as well as for potentiating anticancer drugs an... | 08/25/1992 |
| 5130317 | Pyrimidine-4,6-dicarboxylic acid diamides, processes for the use thereof, and pharmaceuticals based on these compounds Pyrimidine-4,6-dicarboxylic acid diamides, processes for the use thereof, and pharmaceuticals based on these compounds The invention relates to pyrimidine-4,6-dicarboxylic acid diamides of the formula I ##STR1## in which R1 and R2 | 07/14/1992 |
| 4879274 | External medication for skin Novel external medications comprise, as essential components, the following three components (A) to (C): (A) an -monoglyceryl ether represented by the following formula (I): ##STR1## wherein R means an alkyl or alkenyl group having 10 - 24 carbon ... | 11/07/1989 |
| 4602912 | Mothproofing and beetleproofing composition: 5-(pyridyloxy- or thiothenylcarbamoyl)barbituric acid The invention relates to a composition for protecting keratinous material, in particular woollen textiles, from attack by pests that feed on keratin, in particular moth and beetle larvae, which composition contains, as active ingredient combination, a spe... | 07/29/1986 |
| 4503100 | Mothproofing and beetleproofing agent for keratinous material and process A composition for protecting keratin material, in particular woolen textiles, against attack by keratin pests, in particular moth and beetle larvae, which contains a specifically substituted 5-phenylcarbamoylbarbituric acid or a salt thereof and a synthet... | 03/05/1985 |
| 4386085 | Novel steroids Novel 19-nor steroids and 19-nor-D-homo-steroids of the formula ##STR1## wherein R1 is an organic radical of 1 to 18 carbon atoms containing at least one atom selected from the group consisting of nitrogen, phosphorous and silicon with the... | 05/31/1983 |
| 4244837 | Multi-purpose blood diluent for use in electronic blood analysis instrumentation A multi-purpose blood diluent especially suitable for use in electronic enumeration and sizing of blood cells, determination of hemoglobin concentration and their collective indices and platelet parameters in a single blood sample by means of suitable ele... | 01/13/1981 |
| 4185104 | Tranquillizing complexes Discrete tetrameric complexes of malonylurea derivatives are described in which the properties expected of the individual malonylurea derivatives are beneficially modified. The complexes are of high purity and are of considerable value in the treatment of... | 01/22/1980 |
| 4126684 | 4-Amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse 4-Amino-3-p-halophenylbutyric acids, acyl derivatives, esters and/or salts thereof reduce addiction liability, particularly that of narcotics, or the withdrawal symptoms observed after interruption of prolonged use of addicting agents, especially of narco... | 11/21/1978 |
